Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-01 5:20 pm Unchanged | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 16.4% | 0 (Unchanged) | View |
| 2023-10-24 5:00 pm Purchase | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 16.4% | 179,000 (+19.58%) | View |
| 2023-10-13 5:00 pm Purchase | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 914,188 13.7% | 50,000 (+5.79%) | View |
| 2023-09-26 5:19 pm Purchase | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 864,188 13% | 48,060 (+5.89%) | View |
| 2023-09-22 5:21 pm Purchase | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 816,128 12.2% | 153,600 (+23.18%) | View |
| 2023-09-15 5:29 pm Unchanged | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.9% | 0 (Unchanged) | View |
| 2023-08-08 4:41 pm Unchanged | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.9% | 0 (Unchanged) | View |
| 2023-07-17 4:34 pm Unchanged | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.9% | 0 (Unchanged) | View |
| 2023-05-30 4:57 pm Sale | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.9% | -9,955,431 (-93.76%) | View |
| 2023-05-01 4:00 pm Purchase | 13G | MEI Pharma, Inc. MEIP | TANG CAPITAL PARTNERS LP | 361,084 5.4% | 361,084 (New Position) | View |
| 2023-03-09 4:10 pm Sale | 13D | MEI Pharma, Inc. MEIP | Growth Equity Opportunities V LLC | 0 0% | -9,963,216 (Position Closed) | View |
| 2023-02-14 4:07 pm Purchase | 13G | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 10,617,959 8% | 10,130,990 (+2080.42%) | View |
| 2023-02-09 4:04 pm Sale | 13G | MEI Pharma, Inc. MEIP | UBS Oncology Impact Fund L.P. | 0 0% | -10,137,859 (Position Closed) | View |
| 2023-02-09 11:27 am Purchase | 13G | MEI Pharma, Inc. MEIP | VANGUARD GROUP INC | 7,671,024 5.76% | 7,671,024 (New Position) | View |
| 2022-05-31 4:55 pm Sale | 13G | MEI Pharma, Inc. MEIP | First Light Asset Management LLC | 16,000 0.01% | -11,577,712 (-99.86%) | View |
| 2022-04-07 3:20 pm Sale | 13G | MEI Pharma, Inc. MEIP | WASATCH ADVISORS LP | 0 0% | -9,342,310 (Position Closed) | View |
| 2022-02-14 4:45 pm Purchase | 13G | MEI Pharma, Inc. MEIP | First Light Asset Management LLC | 11,593,712 8.73% | 11,593,712 (New Position) | View |
| 2022-02-11 1:38 pm Purchase | 13G | MEI Pharma, Inc. MEIP | WASATCH ADVISORS LP | 9,342,310 7% | 9,342,310 (New Position) | View |
| 2022-02-09 5:22 pm Sale | 13G | MEI Pharma, Inc. MEIP | BlackRock Inc. BLK | 6,637,006 4.99% | -52,865 (-0.79%) | View |
| 2022-01-31 5:49 pm Sale | 13G | MEI Pharma, Inc. MEIP | BlackRock Inc. BLK | 6,689,871 5.9% | -297,805 (-4.26%) | View |